Instrument Inactif

Autres langues ARCS DATAPAR OTC Markets

Actions

SSYNF

GB00BYV3J755

Autres langues

13/08/25	Arcturis Data Limited Reports Earnings Results for the Full Year Ended December 31, 2024
01/10/24	Arcturis and Guy?s and St Thomas? NHS Foundation Trust Enters Strategic Agreement
02/11/23	E-Therapeutics plc Announces Strategic Collaboration with Arcturis Data Limited
27/04/22	Cash-Strapped Sensyne Health to Lay Off Majority of Staff
19/04/22	Sensyne Health Slumps 32% on End of Formal Sale Process, Planned Delisting
19/04/22	Sensyne Health Ends Formal Sale Process With Expanded Note Purchase Agreement
19/04/22	Sensyne Health Names New CEO
19/04/22	Sensyne Health Announces Termination of the Formal Sale Process
13/04/22	Form 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC
08/04/22	Sensyne Health Plummets 85% Amid CEO Change, Revised Financing Deal
08/04/22	Sensyne Health Remains In Talks With Potential Buyers Amid Funding Increase To Continue Operating
08/04/22	Sensyne Health CEO Steps Down; Successor Appointed
08/04/22	Sensyne Health plc Announces Executive Changes
08/04/22	Shares in Sensyne Dive After It Warns on Future, Amends Financing Agreement
04/04/22	Sensyne Health Issues New Shares To US Health Systems As Part Of Strategic Research Agreements
28/03/22	Sensyne Health plc Announces Change in Registered Office
18/03/22	Sensyne Health Issues Equity to Great Ormond Street Hospital for Children
31/01/22	FTSE Flat, Activist Chatter Puts Vodafone Among FTSE 100 Leaders
31/01/22	Sensyne Health plc Reports Earnings Results for the Half Year Ended October 31, 2021
26/01/22	Sensyne Health plc Announces Successful Completion of Financing
26/01/22	Sensyne Health plc announced that it expects to receive £11.35 million in funding
24/01/22	Sensyne Health CEO Mulls Delisting From London's AIM Segment
18/01/22	Invesco Ltd. Form 8.3 Sensyne Health Plc
17/01/22	Form 8.3 - Octopus Investments - Sensyne Health plc
14/01/22	FTSE 100 Closes 0.3% Lower as Royal Mail, B&M Plummet